511 Abbott Rapid Diagnostics Schweiz GmbH 子公司 100.00% 512 Abbott Products (Spain), S.L. 子公司 100.00% 513 Unipath Limited 子公司 100.00% 514 European Services S.A. 子公司 100.00% 515 Abbott Healthcare Products B.V. 子公司 100.00% 516 Abbott Laboratorios del Ecuador Cia. Ltda. 子公司...
罗氏血糖健康医护公司Roche Diabetes Care GmbH 产品技术要求编号 -- 国械注进20162402313 适用范围 -- 本产品用于定量检测取自手指的新鲜毛细血管全血中的血糖浓度。医务人员还可配合使用A…(详见说明书) 贮藏条件 -- 2~30℃保存,有效期18个月。 生产许可证或者备案凭证编号 -- / 医疗器械名称 -- 血糖试纸(葡...
Utilizing its knowledge of intravenous solution production, vitamin therapy, and infant formula, Abbott developed a comprehensive nutritional therapy program to speed the recovery of hospital patients and thereby reduce medical care costs. In the 1980s, as many as 65 percent of all hospital patients ...
ABBOTT PARK, Ill., May 15 /PRNewswire-FirstCall/ -- Abbott Laboratories (NYSE: ABT) announced today a worldwide marketing and distribution agreement with German-based Artus GmbH for the first commercial test to detect a form of the coronavirus suspected of causing Severe ...
罗氏血糖健康医护公司Roche Diabetes Care GmbH 产品技术要求编号 -- 国械注进20162402313 适用范围 -- 本产品用于定量检测取自手指的新鲜毛细血管全血中的血糖浓度。医务人员还可配合使用A…(详见说明书) 贮藏条件 -- 2~30℃保存,有效期18个月。 结构及组成 -- 醌蛋白葡萄糖脱氢酶、吡咯喹啉醌、缓冲剂、稳定剂...
罗氏血糖健康医护公司Roche Diabetes Care GmbH 医疗器械注册证编号或者备案凭证编号 国械注进20163072472 国械注进20162402313 医疗器械类别 Ⅲ类07 Ⅱ类6840体外诊断试剂(诊断试剂不需低温冷藏运输贮存) 适用范围 - 本产品用于定量检测取自手指的新鲜毛细血管全血中的血糖浓度。医务人员还可配合使用A…(详见说明书) 产...
罗氏血糖健康医护公司Roche Diabetes Care GmbH 产品技术要求编号 -- 国械注进20162402313 适用范围 -- 本产品用于定量检测取自手指的新鲜毛细血管全血中的血糖浓度。医务人员还可配合使用A…(详见说明书) 贮藏条件 -- 2~30℃保存,有效期18个月。 生产许可证或者备案凭证编号 ...
(YMC Europe GmbH, Schermbeck, Germany) by running a suitable gradient, such as a gradient from 0 to 90% acetonitrile/TFA 0.05%, within a suitable time, such as within 50 min, at a suitable flow rate, such as at a flow rate of 1.0 ml/min. The detection is to be performed at a ...
Publication Date: 10/26/2004 Filing Date: 03/20/2001 Export Citation: Click for automatic bibliography generation Assignee: Abbott GmbH & Co. KG (DE) Primary Class: 514/14.8 Other Classes: 514/21.92 International Classes: A61K47/48; (IPC1-7): A61K38/28 ...
Owing to their high selectivity for the D3 receptor, the compounds I of the invention are also for the treatment of renal function disorders, especially of renal function disorders caused by diabetes mellitus (see WO 00/67847) and specifically of diabetic nephropathy....